MERCK & CO., INC.

Lobbying client. Federal LDA filings.

Connected on the graph

Inbound (18)

date	from	type	amount	source
—	Jeff Choudhry	lobbied_for	—	lda_lobbyist_client
—	Darren Willcox	lobbied_for	—	lda_lobbyist_client
—	Manny Rossman	lobbied_for	—	lda_lobbyist_client
—	Corey Malmgren	lobbied_for	—	lda_lobbyist_client
—	Kyle Nevins	lobbied_for	—	lda_lobbyist_client
—	Jonathon Jones	lobbied_for	—	lda_lobbyist_client
—	Brett Baker	lobbied_for	—	lda_lobbyist_client
—	Rachel Jones Hensler	lobbied_for	—	lda_lobbyist_client
—	John Michael Gonzalez	lobbied_for	—	lda_lobbyist_client
—	Mary Beth Savary Taylor	lobbied_for	—	lda_lobbyist_client
—	Steve Stombres	lobbied_for	—	lda_lobbyist_client
—	John Leganski	lobbied_for	—	lda_lobbyist_client
—	Jonathan Slemrod	lobbied_for	—	lda_lobbyist_client
—	Greg D'Angelo	lobbied_for	—	lda_lobbyist_client
2026-01-01	W STRATEGIES, LLC	lobbies_for	$50,000	lda_filing
2026-01-01	TIBER CREEK GROUP	lobbies_for	$50,000	lda_filing
2025-01-01	HARBINGER STRATEGIES, LLC	lobbies_for	—	lda_filing
2025-01-01	THE NICKLES GROUP, LLC	lobbies_for	—	lda_filing

Outbound (1)

date	type	to	amount	role	source
2026-01-01	lobbies_on_bill	HR 4299 — Protecting Patient Access to Cancer and Complex Therapies Act	—	H.R. 4299	lobbying_bill_mention

Source id: 63930
General description: Pharmaceutical Company.
State: DC
Country: US
Principal place of business: US
Effective date: 2025-01-13
Total spend (across 1 ingested filings): $0

Filings

Posted	Type	Year	Lobbying firm	Income
2025-01-31	`RR`	2025	HARBINGER STRATEGIES, LLC	—

pac.dog is a free, independent, non-partisan research tool. Every candidate, committee, bill, vote, member, and nonprofit on this site is mirrored from primary U.S. government sources (FEC, congress.gov, govinfo.gov, IRS) and each state's Secretary of State / election commission — no third-party data vendors, no paywall, no editorial intermediation. Citations to the originating source are on every detail page.